4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001193125-26-038002
Chief Financial Officer sold 1,558 shares at $0.98 ($1,521)
- Chief Financial Officer acquired 3,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Broadfoot Jill Marie · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 1 in the form | +3,750 | 38,854 | D | ||
| 2026-02-04 | Sale : show line 2 in the form | −1,558 | $0.98 | $1,521 | 37,296 | D |
| Open-market sales · 1,558 sh · avg $0.98 · $1,521 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-03 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −3,750 | 0 | D |
Loading xslF345X05/ownership.xml…